Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance

被引:0
作者
Probin Kr Roy
Johirul Islam
Hauzel Lalhlenmawia
机构
[1] Regional Institute of Paramedical and Nursing Sciences (RIPANS),Department of Pharmacy
[2] Coromandel International Limited,undefined
来源
The Egyptian Heart Journal | / 75卷
关键词
Adipokines; Adipose tissue dysfunction; Anti-inflammatory adipokines; Atherogenic dyslipidemia; Insulin resistance; Metabolic disorder;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 977 条
[161]  
Xu A(2008)Adiponectin induces NF-κβ activation that leads to suppression of cytokine-induced NF-κβ activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin Diabetes Vasc Disease Res 5 123-212
[162]  
Sung HK(2009)Skeletal muscle insulin resistance is the primary defect in type 2 diabetes Diabetes Care 32 S157-3264
[163]  
Doh KO(2014)Adiponectin and insulin cross talk: the microvascular connection Trends Cardiovasc Med 24 319-258
[164]  
Son JE(2020)Transendothelial insulin transport is impaired in skeletal muscle capillaries of obese male mice Obesity 28 303-177
[165]  
Park JG(2021)Microvascular dysfunction in diabetes mellitus and cardiometabolic disease Endocr Rev 42 29-365
[166]  
Bae Y(2011)Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats Am J Hypertens 24 270-35814
[167]  
Choi S(2011)Adipose tissue-derived omentin-1 function and regulation Compr Physiol 7 765-10315
[168]  
Nagy A(2001)Molecular cloning and functional expression of a human intestinal lactoferrin receptor Biochemistry 40 15771-16313
[169]  
Ruiz-Ojeda FJ(2013)Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome J Clin Endocrinol Metab 98 E514-12162
[170]  
Méndez-Gutiérrez A(2010)Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes Diabetes Res Clin Pract 88 29-430